Borislava Mihaylova

• A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.

  Journal article

  Schlackow I. et al, (2017), Heart

• Body mass index and healthcare costs: a systematic literature review of individual participant data studies.

  Journal article

  Kent S. et al, (2017), Obes Rev, 18, 869 - 879

• The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials.

  Journal article

  Clayton GL. et al, (2017), Trials, 18

• Hospital costs in relation to body mass index in 1.1 million women in England: a prospective cohort study

  Journal article

  Kent S. et al, (2017), Lancet Public Health

• Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.

  Journal article

  Achelrod D. et al, (2017), Eur J Prev Cardiol, 24, 426 - 436

• Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.

  Journal article

  Castellani J. et al, (2016), Clin Infect Dis, 63, S256 - S263

• Quantifying and Valuing Community Health Worker Time in Improving Access to Malaria Diagnosis and Treatment.

  Journal article

  Castellani J. et al, (2016), Clin Infect Dis, 63, S298 - S305

• Are statins useful in patients with advanced chronic kidney disease? - Authors' reply.

  Journal article

  Herrington WG. et al, (2016), Lancet Diabetes Endocrinol, 4, 971 - 972

• HEALTH ECONOMICS ANALYSIS PLANS: WHERE ARE WE NOW?

  Journal article

  Thorn JC. et al, (2016), VALUE IN HEALTH, 19, A397 - A397

• Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

  Journal article

  Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2016), Lancet Diabetes Endocrinol, 4, 829 - 839

• Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs.

  Journal article

  Kent S. et al, (2016), Circ Cardiovasc Qual Outcomes, 9, 348 - 354

• Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.

  Journal article

  Cholesterol Treatment Trialists' (CTT) Collaboration None., (2016), Am Heart J, 176, 63 - 69

• Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).

  Journal article

  Mihaylova B. et al, (2016), Am J Kidney Dis, 67, 576 - 584

• The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.

  Journal article

  Morton RL. et al, (2016), Nephrol Dial Transplant, 31, 46 - 56

• Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.

  Journal article

  Morton RL. et al, (2016), Am J Kidney Dis, 67, 31 - 39

• IMPACT OF EDUCATIONAL ATTAINMENT ON HEALTH OUTCOMES IN MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE

  Conference paper

  Morton RL. et al, (2015), NEPHROLOGY DIALYSIS TRANSPLANTATION, 30

• What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

  Journal article

  Kent S. et al, (2015), BMC Nephrol, 16

• Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

  Journal article

  Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2015), Lancet, 385, 1397 - 1405

• The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).

  Journal article

  Alva ML. et al, (2015), Diabet Med, 32, 459 - 466

• Out-of-pocket costs and other determinants of access to healthcare for children with febrile illnesses: a case-control study in rural Tanzania.

  Journal article

  Castellani J. et al, (2015), PLoS One, 10

• The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity.

  Journal article

  Alva M. et al, (2014), Health Econ, 23, 487 - 500

• Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2).

  Journal article

  ACST-2 Collaborative Group None. et al, (2013), Eur J Vasc Endovasc Surg, 46, 510 - 518

• Authors' reply

  Journal article

  Mihaylova B. et al, (2012), The Lancet, 380, 1817 - 1818

• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

  Journal article

  Cholesterol Treatment Trialists' (CTT) Collaborators None. et al, (2012), Lancet, 380, 581 - 590

• Review of statistical methods for analysing healthcare resources and costs.

  Journal article

  Mihaylova B. et al, (2011), Health Econ, 20, 897 - 916

• Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness.

  Journal article

  Buchanan J. et al, (2010), PLoS One, 5

• RECTAL AND INTRAVENOUS ARTESUNATE FOR SEVERE MALARIA: MODELLING THE IMPACT OF ARTEMISININ RESISTANCE

  Conference paper

  Maude RJ. et al, (2010), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 83, 377 - 377

• Estimating the quality of life impact of diabetes related complications: new results from the UKPDS

  Conference paper

  Alva ML. et al, (2010), DIABETOLOGIA, 53, S52 - S52

• Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study.

  Journal article

  Mihaylova B. et al, (2010), Value Health, 13, 565 - 572

• Statin cost-effectiveness in the United States for people at different vascular risk levels.

  Journal article

  Heart Protection Study Collaborative Group None., (2009), Circ Cardiovasc Qual Outcomes, 2, 65 - 72

• Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.

  Journal article

  Briggs A. et al, (2007), Heart, 93, 1081 - 1086

• Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.

  Journal article

  Heart Protection Study Collaborative None. et al, (2006), BMJ, 333

• The cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

  Conference paper

  Briggs A. et al, (2006), HEART, 92, A36 - A36

• Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial

  Conference paper

  Mihaylova B. et al, (2005), CIRCULATION, 112, U900 - U901

• Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.

  Journal article

  Mihaylova B. et al, (2005), Lancet, 365, 1779 - 1785

• Economic evaluation of the Heart Protection Study

  Conference paper

  Briggs A. et al, (2003), CIRCULATION, 108, 776 - 776

• Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation.

  Journal article

  Bryant J. et al, (2002), Health Technol Assess, 6, 1 - 106

• Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.

  Journal article

  Bryant J. et al, (2002), Health Technol Assess, 6, 1 - 168

• Procedural risks of carotid endarterectomy and carotid artery stenting over time: A Systematic Review and Meta-Analysis.

  Journal article

  Lokuge K. et al, British Journal of Surgery

Recent Publications

• A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.

  Journal article

  Schlackow I. et al, (2017), Heart

• Body mass index and healthcare costs: a systematic literature review of individual participant data studies.

  Journal article

  Kent S. et al, (2017), Obes Rev, 18, 869 - 879

• The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials.

  Journal article

  Clayton GL. et al, (2017), Trials, 18

• Hospital costs in relation to body mass index in 1.1 million women in England: a prospective cohort study

  Journal article

  Kent S. et al, (2017), Lancet Public Health

• Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.

  Journal article

  Achelrod D. et al, (2017), Eur J Prev Cardiol, 24, 426 - 436